Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy. [PDF]
Zamaria JA +3 more
europepmc +6 more sources
Older Adults in Psychedelic-Assisted Therapy Trials: A Systematic Review [PDF]
Background: Growing clinical interest in psychedelic-assisted therapies has led to a second wave of research involving psilocybin, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA) and other substances.
Bouchet L +7 more
europepmc +3 more sources
Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design. [PDF]
Psychedelic-assisted therapy (PAT) has typically been evaluated using conventional randomised controlled trials (RCTs), which assess treatment efficacy under highly controlled conditions.
Muthumaraswamy SD +6 more
europepmc +2 more sources
Mechanisms of integration in psychedelic-assisted therapy. [PDF]
LAY SUMMARY Psychedelic pharmacotherapies combined with structured psychotherapy have shown promise in the treatment of several psychological conditions. This type of therapy is known as psychedelic-assisted psychotherapy (PAP) and includes three phases: preparation, in-session support, and integration.
Coverdale NS, Cook DJ.
europepmc +3 more sources
Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review. [PDF]
Background: Psychedelic-assisted therapy (PAT) has demonstrated substantial efficacy across a range of mental disorders. However, heterogeneity between patients confers differential responsiveness. This systematic review aims to explore factors which may
Viljoen G +4 more
europepmc +2 more sources
Psychedelic-assisted therapy: An overview for the internist
Preliminary evidence suggests that psychedelic-assisted therapy—the enhancement of psychotherapy with psychedelics such as 3,4-methylenedioxymethamphet-amine (MDMA) and psilocybin—may be efficacious for depression, posttraumatic stress disorder ...
B. Barnett +2 more
semanticscholar +3 more sources
Further education in psychedelic-assisted therapy - experiences from Switzerland. [PDF]
The growing interest in psychedelic-assisted therapy (PAT) for treating psychiatric disorders such as treatment-resistant depression, PTSD, and anxiety has led to an increasing demand for specialized training.
Aicher HD, Müller F, Gasser P.
europepmc +2 more sources
Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program. [PDF]
This article describes the Swiss limited access program for psychedelic/3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy. The Swiss Federal Office of Public Health can issue authorizations for the limited medical use of otherwise prohibited ...
Liechti ME +5 more
europepmc +2 more sources
Oncology Providers' Perspectives on Psychedelic-Assisted Therapy. [PDF]
Purpose Despite most psychedelic substances remaining Schedule I, clinical research exploring psychedelic-assisted therapy (PAT) in oncology is expanding. We sought to assess oncology providers’ attitudes toward and understanding of PAT. Methods
Hanubal KS +8 more
europepmc +3 more sources
Not a Standalone Treatment: Considerations for Psychedelic-Assisted Therapy. [PDF]
ABSTRACT Purpose Psychedelic‐assisted therapy (PAT) is becoming a clinically available treatment for patients with treatment‐resistant conditions such as depression and post‐traumatic stress disorder (PTSD) in several countries.
Murphy S +5 more
europepmc +4 more sources

